Sarah McCue’s Post

This is huge for anyone battling Rheumatoid Arthritis Warrior! Mesenbio, a University of York spin-out, just secured £1.4m to move closer to developing a groundbreaking treatment. Here's what you need to know: 1. They're using engineered stem cells to create nano-sized messengers (EVs). 2. These EVs reduce inflammation and repair damaged tissue – not just relieve pain. 3. Funding will fast-track pre-clinical studies and prep for human trials. Imagine a treatment that not only stops arthritis pain but helps your body heal. Mohammad Khobreh, Jason Goldstein, Hossein Malekmadani, Faezeh Rakhshan, Melika Parva P.S. How amazing would it be to see this breakthrough in the clinic? https://lnkd.in/dHw_NcTa #HealthTech #ArthritisTreatment #StemCellTherapy

Advances in Regenerative Medicine: A New Era for Heart and Lung Restoration In regenerative medicine, pioneering therapies are emerging that could redefine how we address heart and lung damage. Researchers are developing techniques to regenerate heart muscle post-infarction and repair lung tissue affected by fibrosis. These innovations represent a shift from chronic disease management to the restoration of full organ function. Through cutting-edge stem cell and microRNA therapies, the potential to renew vital organs is within reach. With human trials anticipated by 2026, the vision of restoring cardiac and pulmonary health may soon become reality. #RegenerativeMedicine #HealthcareInnovation #Cardiology #Pulmonology

Breakthrough Alert in Organ Engineering! #Science is on the brink of something extraordinary—regenerating hearts, lungs, and other vital organs. This article from The Wall Street Journal explores how cutting-edge #research advances tissue growth techniques that could one day redefine transplantation and save countless lives. Discover the innovative strategies #scientists like Michael Bollong are using here Scripps Research, from #bioengineered scaffolds to stem cell therapies, and how these developments might transform the future of #medicine.

Amazing and exciting work published! An international research team including researchers at KI, Edinburgh University and Hoffmann-La Roche in Basel, among other institutions, created an ‘atlas of MS brain cells’ at an individual cell resolution, by examining the largest-ever number of donor brains with MS, comprising more than half a million brain cells.

U.S. children with inoperable brain tumors appear to die sooner and find it harder to get care if they live in poorer neighborhoods, a new study finds. https://lnkd.in/ekqCE7_8 #ChildhoodCancer #BrainTumor #HealthDisparities #CancerResearch #HealthEquity #MedicalResearch #CancerAwareness #HealthcareDisparities

There’s some hopeful news in Parkinson’s research that might help a lot of patients. Researchers have found a way to stop dyskinesia, those uncontrollable movements that can happen with long-term treatment. They did this by blocking a specific protein and treating dyskinesia like a “bad motor memory.” This could make a big difference in how well current Parkinson’s treatments work, helping patients stay mobile and independent longer. It's a great example of how ongoing research can lead to real improvements in people’s lives. #parkinsonsdisease #dyskinesia #healthresearch #healthinnovation #healthadvancement #healthnews https://lnkd.in/g9MchPvJ

As a #urologiconcologist, Wei Shen Tan, MD, PhD, guides patients from #cancer diagnosis to joint decision-making on how to move forward. In this 1-minute video by Yale Medicine, hear why Dr. Tan is interested in tailoring treatment for his patients. #WelcomeToTheTeam Yale School of Medicine

New treatment with the potential to reduce the lifelong impacts of perinatal lung and brain injuries aims to help children born #Preterm who are at increased risk of developing #BronchopulmonaryDysplasia (#BPD) and #CerebralPalsy (#CP). 🫁🧠 Dr Ishmael (Mikee) Inocencio's analysis of research into extracellular vesicles (EVs) derived from human amniotic epithelial cells (hAECs) has found they have anti-inflammatory and regenerative properties that give them therapeutic advantages over traditional cell-based therapies. 🔬 Learn more about this #Research here: https://bit.ly/3MvZCqy

Tissue-engineering techniques are in the works to regrow heart muscle after a heart attack and repair lungs and other organs. The idea “is really to restore function to the organ such that the quality of life of that person is normalized,” says Peter Schultz, president and chief executive of Scripps Research, a nonprofit scientific institute in La Jolla, Calif., that is testing medicines to regenerate hearts, lungs and other organs. The need for regenerated hearts alone is huge. Up to 3% of the world’s population suffers from heart failure, in which a heart whose muscle has been damaged by a heart attack or another disease gradually loses its ability to pump blood. The condition affects about 6.5 million people in the U.S. and is the leading cause of hospitalization among Medicare patients. Certain salamanders and zebrafish can regenerate their hearts, along with limbs and other organs. Humans have only a limited capacity to regenerate, with skin and the liver as the main examples. They die with most of the same heart-muscle cells they were born with. “We’re built for performance and not repair,” says Dr. Chuck Murry, director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of Southern California’s Keck School of Medicine. "One billion heart-muscle cells—about 25% of muscle cells in the left ventricle—can die as a result of a major heart attack, when blood flow to the heart muscle is abruptly cut off", says Dr. Mauro Giacca, head of the School of Cardiovascular and Metabolic Medicine & Sciences at King’s College London. The left ventricle is the heart’s main pumping chamber.  Giacca is developing a therapeutic that uses microRNA, molecules that help regulate how genes are expressed, to induce surviving cardiac cells to multiply. Scripps Research scientists are working on a drug to grow new heart muscle from surviving heart-muscle cells. Another scientist, Doris Taylor, is working on growing entire hearts.

From Heart Failure to Successful Treatment!    Duke-NUS Medical School researchers say that regenerative stem cells might be the answer to fixing hearts that are damaged. These cells can grow into different types of heart cells, helping mend hearts suffering from diminished blood flow.    While this breakthrough research opens up new promises to treat heart problems more effectively, we must remember that regular monitoring of the heart is the key to early detection of symptoms and timely treatment. Use SanketLife to track your heart health and detect heart risks. Explore SanketLife Pocket ECG👇 https://bit.ly/3ZNrlrd . . . #stemcells #stemcelltherapy #stemcelltreatment #heart #hearthealth #heartdisease #earlydetection #regularmonitoring #ecg #explorepage #agatsa #sanketlife